Global Prostate Cancer Testing Market Research Report 2022

SKU ID : QYR- 21296735

Publishing Date : 12-Jul-2022

No. of pages : 89


  • Market Analysis and Insights: Global Prostate Cancer Testing Market
    Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
    The global Prostate Cancer Testing market size is projected to reach US$ 22660 million by 2028, from US$ 13430 million in 2021, at a CAGR of 7.6% during 2022-2028.
    The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Testing market in terms of revenue.
    Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Testing market.
    Global Prostate Cancer Testing Scope and Market Size
    Prostate Cancer Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
    Segment by Type
    PSA Tests
    CTC Tests
    PCA3 Tests
    Segment by Application
    Hospital Associated Labs
    Independent Diagnostic Laboratories
    Cancer Research Institutes
    By Region
    North America
    United States
    Nordic Countries
    Rest of Europe
    South Korea
    Southeast Asia
    Rest of Asia
    Latin America
    Rest of Latin America
    Middle East & Africa
    Saudi Arabia
    Rest of MEA
    By Company
    Genomic Health
    Siemens Healthcare
    MDx Health
    Beckman Coulter
    Myriad Genetics
    Ambry Genetics

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports